$AUBN

AUBURN NATIONAL BANCORPORATION, INC (AUBN): Results of Operations and Financial Condition

AUBURN NATIONAL BANCORPORATION, INC (AUBN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d183013dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 For additional information, contact: David A. Hedges President and CEO (334) 821-9200 Press Release – July 28, 2026 Auburn National Bancorporation, Inc. Reports Second Quarter Net Earnings Second Quarter 2026 vs. Second Qua

Original reporting
Published Jul 28, 2026, 7:32 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 28, 2026, 7:37 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$AUBN
Bullish
medium confidence
Mentioned
$AUBN
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$AUBNBullishMed
01

Why it matters

Key trading-relevant items are EPS growth, net interest margin expansion, and improved asset quality reflected in very low nonperforming assets and a negative provision for credit losses.

02

Market read

The filing provides fresh quarterly fundamentals that can re-rate expectations for profitability and credit costs, but lacks forward-looking guidance.

03

What to watch

Deposit growth is partly driven by reciprocal deposits retained on balance sheet, which may be more volatile than core deposits; also, no explicit guidance is provided.

Relevance 7/10Novelty 6/10Timing: after-hours filing of 2Q 2026 results on July 28, 2026

Background

This is an SEC Form 8-K (Item 2.02) with Exhibit 99.1 reporting Auburn National Bancorporation’s second-quarter 2026 operating results and financial condition.

Company-level read

Ticker impact

$AUBNBullishMedium confidence
Context

Auburn National Bancorporation reported 2Q 2026 net earnings of $2.3M, EPS $0.66, and a 3.33% net interest margin.

Expected impact

Mildly positive bias for the next few sessions, assuming investors focus on NIM expansion and low nonperforming assets.

Evidence & confidence

The filing provides multiple directionally favorable datapoints (EPS +27%, NIM +15 bps QoQ, nonperforming assets 0.01%, negative provision for credit losses) but no explicit forward guidance or balance-sheet action beyond reported quarter-end levels.

Market effects

Adds another datapoint on small-bank net interest margin resilience and credit-loss normalization, relevant to regional bank read-through.

Limited to local/regional banking sentiment given the company’s Auburn, Alabama footprint.

Low; no macro or cross-border drivers disclosed.

Counterpoint

The quarter includes a loss contingency accrual and a CECL methodology refinement, which could make credit metrics less comparable quarter-to-quarter.

Key entities

  • Auburn National Bancorporation, Inc.

    Nasdaq-listed community bank reporting 2Q 2026 earnings, NIM, credit-loss provision, and balance-sheet metrics.

Related articles

$MURMedAI 8/10

Murphy Oil Sees Sharp Profit Increase

Murphy Oil Corp reported Q2 2026 adjusted net income of $225.8 million, nearly six times Q2 2025, as higher oil prices offset lower production and weaker gas. Adjusted EPS was $1.55 vs $1.51 consensus. Revenue rose to $926.3 million. Murphy kept its $0.35 dividend and raised 2026 capex midpoint to $1.55 billion.

$GSBDMed

Goldman Sachs BDC Q2 Earnings Call Highlights

Goldman Sachs BDC (NYSE:GSBD) reported no incentive fee in Q2, citing its three-year total-return lookback provision. NAV was $12.06/share at June 30 vs $12.17 in Q1. The board declared a Q3 base dividend of $0.32/share plus $0.03 supplemental. Investments were $3.2B fair value, non-accrual 2.9%, and net debt-to-equity 1.35x.

$HBBMed

Hamilton Beach Brands Q2 Earnings Call Highlights

Hamilton Beach Brands (HBB) reported Q2 gross margin of 26.1% excluding tariff-related benefits, and said it expects 2026 revenue growth in the mid-single-digit range. Management forecast full-year gross margin to improve modestly and operating profit to decline by a high-single-digit percentage. Operating cash flow is expected at $35M to $45M. HBB ended with net cash of $51.5M.

$GXOMed

GXO Logistics Q2 Earnings Call Highlights

GXO Logistics reported Q2 results and said it secured over $1 billion in expected incremental new-business revenue for 2026 and about $353 million for 2027. Management cited a $2.7 billion sales pipeline after quarter end. Operating cash flow was $76 million, free cash flow positive $12 million, cash $769 million, and net leverage 2.6x. GXO plans to target EBIT margins above 6% and deploy AI across ~50 sites in 2026.

$GRNDMed

Grindr Q2 Earnings Call Highlights

Grindr (NYSE:GRND) said free users remain central to its strategy, while AI tools are boosting engineering productivity. Management estimated engineering output rose about 2.5x from July 2025 to April 2026 with similar headcount, supporting a 39% to 42% adjusted EBITDA margin outlook. EDGE AI premium tier rollout is planned for later in fall; operating expenses ex cost of revenue were $71M vs $53M.

$HAEMedAI 8/10

Haemonetics Q1 Earnings Call Highlights

Haemonetics (NYSE:HAE) reported Q1 interventional technologies returning to 3% organic growth, with vascular closure led by VASCADE MVP and MVP XL momentum in the U.S. Apheresis revenue rose 6% organically to $191M and plasma revenue grew 8% organically as Persona PLUS rollout accelerates. Haemonetics raised FY2027 revenue guidance to 5% to 8% reported and 4% to 7% organic.